Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Drug and Alcohol Review|May 5, 2024
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in AustraliaSimon Clay, Zachary Wilkinson, Meredith Ginley, et al.
BMJ Open|February 7, 2025
Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Drug and Alcohol Review|December 5, 2025
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on OpioidsM J Stowe, Anna Conway, Frederick L Altice, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
The International Journal on Drug Policy|May 9, 2022
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage studyHeather Valerio, Maryam Alavi, Anna Conway, et al.
The International Journal on Drug Policy|May 25, 2024
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugsTimothy R Broady, Heather Valerio, Maryam Alavi, et al.
Viruses|July 27, 2022
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage StudyAnna Conway, Heather Valerio, Maryam Alavi, et al.
Trials|June 21, 2024
A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina TrialRebecca McKetin, Tayla J Degan, Lucy Saunders, et al.
Pageof 3